Doha : The newly established International Islamic Association for Bioethics ( IIBA ), under the umbrella of Hamad Bin Khalifa University, held its first meeting, in a significant and important step towards promoting dialogue on bioethics from an Islamic perspective.

The idea for establishing the association crystallized following the resounding success of Hamad Bin Khalifa University in hosting the 17th World Congress on Biomedical Ethics in 2024, the first time it was held in the Arab world and the Middle East region. This step also builds upon the momentum generated by the "Artificial Intelligence Ethics: The Meeting of Ethical Values and the Technological Revolution" conference, which the university organized in 2025. These initiatives embody the university's unwavering commitment to promoting Islamic ethics, a field in which the Center for Islamic Legislation and Ethics ( CILE ), one of the university's research centers, is a global leader, positioning the university as a premier platform for ethics across various fields, including healthcare, artificial intelligence, and sustainability.

As the institutional host of the association, Hamad Bin Khalifa University works to foster a sustainable academic community, support multidisciplinary research, and ensure that Islamic ethical perspectives and concepts are represented in global dialogues on health, technology, and society.

The association’s founding meeting was held at the university’s main campus and the Two Minarets Building in Education City, where Dr. Mohamed Ghaly, the association’s founding president, delivered an opening lecture entitled: “A Voice, Not an Echo: Islamic Medical and Bioethics in Dialogue with the World,” with the participation of a select group of scholars, researchers, students, and experts in the medical and healthcare sector.

The meeting focused on examining ethical issues related to healthcare and biomedical research from the perspective of Islamic ethical thought. It also included interactive panel discussions and a roundtable with key stakeholders entitled "Dialogue with the Healthcare and Biomedical System in Qatar."

Over two days, this meeting positioned Hamad Bin Khalifa University as a leader in shaping the future of Islamic medical and bioethics, translating the field of ethical studies into practical guidelines and strategic direction. The meeting's events included a public lecture titled "The Future of Our Bodies: Islamic Ethics in the Age of Artificial Intelligence and the Genetic Engineering Revolution," which addressed the ethical challenges associated with rapid technological advancements in the absence of necessary frameworks and standards.

Commenting on the importance of this meeting, Dr. Mohamed Ghaly, Professor of Islamic Bioethics at Hamad Bin Khalifa University, President of the Center for Islamic Legislation and Ethics, and Founding President of the International Islamic Bioethics Association, said: “We are proud to host the inaugural meeting of the Association and to provide a leading global platform for Islamic bioethics, rooted in the intellectual heritage of Islamic civilization and keeping pace with contemporary ethical challenges. Through this platform and its sister initiatives in the field of Islamic ethics, Hamad Bin Khalifa University contributes to formulating enlightened, values-based concepts for dealing with ethical challenges related to artificial intelligence, public health, sustainable development, and social cohesion.”

This inaugural meeting, in general, affirms Hamad Bin Khalifa University’s position as a global authority in the field of Islamic medical and bioethics, and promotes dialogue that guides policy, fosters innovation, and links ethical thought with practical application.

About Hamad Bin Khalifa University:

Innovation that shapes tomorrow

Hamad Bin Khalifa University (HBKU), a member of Qatar Foundation for Education, Science and Community Development, is a leading innovation-focused university committed to advancing education and research to address the major challenges facing Qatar and the world. The university develops multidisciplinary academic programs and fosters national research capabilities that drive collaboration with leading global institutions. HBKU is dedicated to cultivating future leaders with an entrepreneurial mindset and developing innovative solutions that have a positive global impact.

For more information about Hamad Bin Khalifa University, please visit: https://www.hbku.edu.qa/ar

For media inquiries, please contact us via email at: media@hbku.edu.qa

About the International Islamic Association for Medical and Bioethics ( IIBA ):

The International Islamic Bioethics Association ( IIBA ) is a global initiative launched by Hamad Bin Khalifa University, bringing together diverse stakeholders. It was established as a global platform uniting those involved in Islamic bioethics, a field of knowledge that has long been fragmented across multiple disciplines. The association is dedicated to promoting interdisciplinary research, fostering connections between scholars, experts, and policymakers worldwide, and ensuring the inclusion of sound Islamic perspectives in global ethical discussions related to fields such as health, technology, and society. The IIBA also aims to stimulate collaboration with individuals and institutions and develop global bioethics programs and initiatives by contributing the rich and diverse insights rooted in the ethical and intellectual heritage of Islamic civilization to address the major ethical challenges of our time.

For more information about the International Islamic Association for Medical and Bioethics, please visit: International Islamic Association for Medical and Bioethics .

Disclaimer regarding the content of press releases
The content of this press release is provided by a third-party provider. We do not assume any responsibility for, nor do we have any control over, such content. This content is provided on an "as is" and "as available" basis and is not edited in any way. Neither we, nor our affiliates, will be liable for the accuracy, endorsement, or completeness of any opinions, views, information, or materials contained in this content.
This press release is provided for informational purposes only; the content does not constitute legal, investment, or tax advice, nor does it offer any opinion on the suitability, value, or profitability of any particular portfolio or investment strategy. Neither we nor our affiliates will be liable for any errors or inaccuracies in the content, or for any actions you take based on that content. You expressly agree and acknowledge full responsibility for your use of the information contained in this press release.
To the extent permitted by applicable law, Refinitiv, its parent company, subsidiaries, affiliates, relevant shareholders, directors, officers, employees, agents, advertisers, content providers, and licensors (collectively, the 'Refinitiv Parties') shall not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive, or exemplary damages; This includes, but is not limited to, losses of profits, savings, or revenues, whether due to negligence, tort, contract, or other theories of liability, even if the parties to Refinitiv were advised of the possibility of any such damages or losses occurring or actually anticipated them.